Topic

personalized mRNA cancer vaccine

Sign in to follow personalized mRNA cancer vaccine

Latest news

26 Oct
Moderna and Merck say personalized mRNA cancer vaccine cut melanoma death, recurrence 42%
Moderna and Merck reported that a personalized mRNA cancer vaccine reduced death and recurrence in melanoma patients by 42%. The result comes from a clinical trial announced in October 2026.
Research · 1 source

Articles

No articles about personalized mRNA cancer vaccine yet.